PubMed HealthSearch

Biomedical subjects

M Mak

Publications and source records attributed to M Mak.

4 recordsLinked to original sources

Protein surface topology-probing by selective chemical modification and mass spectrometric peptide mapping.

Aminoacetylation of lysine residues and the modification of arginine by 1,2-cyclohexanedione to N7,N8-(dihydroxy-1,2-cyclohexylidene)arginine were used for probing the surface topology of hen-eggwhite lysozyme as a model protein. The molecular identification of lysine and arginine modification sites was provided by molecular weight determinations of modified and unmodified tryptic peptide mixtures (peptide mapping) using 252Cf plasma desorption mass spectrometry. At conditions of limited chemical modification, mass-spectrometric peptide-mapping analyses of lysozyme derivatives enabled the direct assignment of relative reactivities of lysine and arginine residues at different reaction times and reagent concentrations. The relative reactivities of lysine residues showed a direct correlation with their surface accessibilities from x-ray structure data. For the reaction with 1,2-cyclohexanedione, a selective modification at Arg-5, -125, -112, and -73 was identified, and an inverse correlation of relative reactivities with the surface accessibility ratios of the N7- and the N8-guanidino functions was obtained. By examination of the x-ray structural data of lysozyme, this selective modification was attributed to intramolecular catalysis because of the presence of neighboring proton acceptor groups, such as the Asp-119 carboxylate group for Arg-125 and the Trp-123 and Arg-125 carbonyl groups for Arg-5.

Acetylation

Effect of dobutamine on oxygen supply and uptake in healthy volunteers.

We have measured the changes in VO2 and the VO2:DO2 relationship during infusion of dobutamine in healthy volunteers. Nine healthy, adult, non-obese, male physicians were infused with an incremental infusion of dobutamine starting at 2.5 micrograms kg-1 min-1 increasing to 5.0 and then 7.5 micrograms kg-1 min-1 for 15 min each. VO2 and cardiac index were measured every five minutes. VO2I (VO2m-2) increased from a baseline of 128 (SEM 6.1) ml min-1 m-2 to 159 (8.0) ml min1 m-2 (P < 0.05) at the end of infusion with 7.5 micrograms kg-1 min-1. The corresponding changes for DO2I (DO2 m-2) were from 643 (35) ml min-1 m-2 to 1240 (142) ml min-1 m-2 (P < 0.05). The coefficient of correlation for pairs of VO2 and DO2 values, at baseline and each dobutamine infusion in individual subjects, ranged from 0.89 to 0.99 (mean 0.95, SD 0.03). Dobutamine has potent calorigenic effects; demonstration of a positive correlation between VO2 and DO2 after infusion of dobutamine does not necessarily imply an underlying tissue oxygen debt.

Adult

Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.

The kinetics, safety and tolerability of eltoprazine hydrochloride were studied in an open, cross-over, partially randomised design after single oral (8 mg) and intravenous (3 and 8 mg) doses to 12 healthy male subjects. After intravenous administration, the mean t1/2 ranged from 7 to 9 h, the MRT was 11 h, CL was 487 +/- 148 (3 mg dose) and 471 +/- 56 (8 mg dose) ml kg-1 h-1, while CLR was 226 +/- 124 (3 mg dose) and 189 +/- 38 (8 mg dose) ml kg-1 h-1. The Vss was 3.3 +/- 0.7 (3 mg dose) and 3.8 +/- 0.5 (8 mg dose) 1 kg-1. Cumulative renal excretion was 40%. The AUC and the cumulative urinary excretion were directly proportional to dose within the range of 3-8 mg. Values of tmax varied from 1 to 4 h after oral administration. The mean Cmax value was 24 ng ml-1 after an oral dose of 8 mg. The plasma elimination half-life after oral administration was 9.8 +/- 3.9 h. Absolute oral bioavailability was 110 +/- 32%. Dose-dependent somnolence was observed.

Administration, Oral